Alembic Pharmaceuticals Complete Financial Statements
APLLTD • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Alembic Pharmaceuticals (APLLTD).
Downloads include all available records across all periods.
For market performance, see the
APLLTD stock price today
.
Profitability Ratios
Net Profit Margin
9.59%
2025 data
EBITDA Margin
16.88%
2025 data
Operating Margin
17.00%
2025 data
Return on Assets
2.37%
2025 data
Return on Equity
3.55%
2025 data
Balance Sheet Ratios
Current Ratio
23.91
2025 data
Debt to Equity
1.50
2025 data
Equity Ratio
66.77%
2025 data
Asset Turnover
0.25
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+14.4%
Year-over-Year
Net Profit Growth
+20.3%
Year-over-Year
EBITDA Growth
+20.0%
Year-over-Year
Expense Growth
+13.2%
Year-over-Year
Assets Growth
+20.6%
Year-over-Year
Equity Growth
+7.7%
Year-over-Year
Liabilities Growth
+20.6%
Year-over-Year
Operating Cash Flow Growth
-89.0%
Year-over-Year
Investing Cash Flow Growth
-76.9%
Year-over-Year
Financing Cash Flow Growth
+201.4%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,919 | 1,784 | 1,717 | 1,678 | 1,521 | 1,564 | 1,703 | 1,605 | 1,407 | 1,498 | 1,634 | 1,475 | 1,426 | 1,263 | 1,510 | 1,313 | 1,306 | 1,328 | 1,291 | 1,460 | 1,243 | 1,342 | 1,317 | 1,241 | 930 | 952 | 1,210 | 1,129 | 854 | 863 | 1,022 | 797 | 742 | 648 | 840 | 880 | 630 | 737 | 777 | 1,003 | 504 | 582 | 918 |
| Expenses | 1,595 | 1,498 | 1,430 | 1,409 | 1,257 | 1,325 | 1,433 | 1,387 | 1,203 | 1,288 | 1,364 | 1,244 | 1,268 | 1,255 | 1,274 | 1,054 | 960 | 1,090 | 1,030 | 1,014 | 926 | 934 | 949 | 895 | 749 | 757 | 884 | 825 | 680 | 712 | 776 | 610 | 606 | 547 | 653 | 702 | 484 | 580 | 632 | 629 | 405 | 478 | 532 |
| EBITDA | 324 | 286 | 287 | 270 | 263 | 239 | 270 | 218 | 205 | 210 | 269 | 231 | 158 | 9 | 236 | 259 | 346 | 238 | 261 | 447 | 318 | 408 | 368 | 346 | 181 | 195 | 326 | 305 | 174 | 151 | 246 | 187 | 136 | 102 | 188 | 178 | 146 | 158 | 146 | 375 | 99 | 103 | 386 |
| Operating Profit Margin % | 17.00% | 15.00% | 16.00% | 15.00% | 17.00% | 15.00% | 15.00% | 13.00% | 14.00% | 13.00% | 16.00% | 16.00% | 10.00% | 1.00% | 16.00% | 18.00% | 25.00% | 18.00% | 19.00% | 30.00% | 23.00% | 30.00% | 28.00% | 28.00% | 19.00% | 20.00% | 27.00% | 27.00% | 20.00% | 18.00% | 24.00% | 23.00% | 18.00% | 16.00% | 22.00% | 20.00% | 23.00% | 21.00% | 19.00% | 37.00% | 19.00% | 18.00% | 42.00% |
| Depreciation | 76 | 69 | 74 | 71 | 70 | 69 | 70 | 68 | 74 | 66 | 69 | 68 | 123 | 67 | 67 | 55 | 51 | 53 | 56 | 44 | 44 | 42 | 47 | 36 | 30 | 35 | 42 | 29 | 32 | 28 | 29 | 26 | 22 | 22 | 26 | 21 | 24 | 19 | 21 | 13 | 11 | 13 | 22 |
| Interest | 24 | 25 | 24 | 19 | 11 | 13 | 22 | 16 | 14 | 14 | 15 | 12 | 7 | 9 | 15 | 5 | 3 | 2 | 4 | 5 | 8 | 7 | 2 | 7 | 5 | 5 | 7 | 6 | 1 | 2 | 6 | 0 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 1 |
| Profit Before Tax | 224 | 192 | 190 | 180 | 183 | 157 | 178 | 135 | 116 | 130 | 185 | 151 | 29 | -67 | 155 | 200 | 292 | 183 | 201 | 398 | 266 | 360 | 318 | 303 | 146 | 155 | 276 | 270 | 141 | 122 | 211 | 161 | 112 | 79 | 161 | 157 | 120 | 137 | 124 | 362 | 89 | 91 | 364 |
| Tax | 40 | 35 | 37 | 27 | 5 | 23 | 40 | -2 | -36 | 9 | 4 | 18 | 7 | -2 | 33 | 36 | 49 | 24 | 29 | 73 | 62 | 66 | 33 | 52 | 23 | 36 | 49 | 70 | 47 | 32 | 42 | 39 | 19 | 12 | 30 | 37 | 29 | 33 | 37 | 73 | 18 | 19 | 95 |
| Net Profit | 184 | 157 | 154 | 153 | 178 | 135 | 138 | 137 | 153 | 121 | 180 | 133 | 22 | -66 | 122 | 164 | 243 | 158 | 172 | 325 | 204 | 293 | 286 | 250 | 124 | 120 | 227 | 200 | 94 | 90 | 169 | 122 | 93 | 67 | 131 | 120 | 91 | 104 | 87 | 289 | 70 | 72 | 269 |
| Earnings Per Share (₹) | 9.40 | 7.98 | 7.85 | 7.79 | 9.07 | 6.84 | 7.01 | 6.95 | 7.76 | 6.14 | 9.23 | 6.78 | 1.11 | -3.35 | 6.20 | 8.34 | 12.75 | 8.37 | 8.74 | 17.24 | 11.93 | 15.99 | 14.88 | 13.06 | 6.58 | 6.56 | 12.42 | 10.61 | 4.98 | 4.80 | 9.01 | 6.45 | 4.94 | 3.54 | 6.93 | 6.36 | 4.82 | 5.50 | 4.59 | 15.30 | 3.73 | 3.72 | 14.26 |
Related Pages for Alembic Pharmaceuticals
Additional stock information and data for APLLTD
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 7,773 | 6,446 | 6,183 | 7,122 | 6,709 | 5,989 | 4,778 | 3,941 | 2,689 | 2,429 | 1,641 |
| Current Assets | 4,088 | 3,079 | 2,910 | 2,861 | 2,652 | 2,463 | 1,958 | 1,825 | 1,373 | 1,511 | 891 |
| Fixed Assets | 2,524 | 2,547 | 2,398 | 1,798 | 1,788 | 1,552 | 1,159 | 993 | 799 | 708 | 547 |
| Capital Work in Progress | 837 | 524 | 601 | 2,304 | 2,183 | 1,846 | 1,551 | 1,010 | 396 | 93 | 83 |
| Investments | 127 | 93 | 96 | 118 | 236 | 18 | 49 | 42 | 50 | 53 | 0 |
| Other Assets | 4,285 | 3,282 | 3,087 | 2,902 | 2,502 | 2,573 | 2,019 | 1,896 | 1,444 | 1,575 | 1,011 |
| LIABILITIES | |||||||||||
| Total Liabilities | 7,773 | 6,446 | 6,183 | 7,122 | 6,709 | 5,989 | 4,778 | 3,941 | 2,689 | 2,429 | 1,641 |
| Current Liabilities | 171 | 172 | 175 | 168 | 361 | 1,047 | 570 | 576 | 94 | 84 | 72 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 5,190 | 4,818 | 4,371 | 5,238 | 5,067 | 3,190 | 2,718 | 2,220 | 1,902 | 1,597 | 885 |
| Share Capital | 39 | 39 | 39 | 39 | 39 | 38 | 38 | 38 | 38 | 38 | 38 |
| Reserves & Surplus | 5,152 | 4,779 | 4,331 | 5,198 | 5,028 | 3,182 | 2,681 | 2,182 | 1,865 | 1,560 | 847 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 88 | 803 | 724 | 552 | 1,463 | 449 | 812 | 312 | 329 | 948 | 172 |
| Investing Activities | -568 | -321 | -448 | -372 | -840 | -731 | -756 | -884 | -486 | -307 | -256 |
| Financing Activities | 444 | -438 | -262 | -217 | -597 | 155 | 59 | 503 | -129 | -224 | 87 |
| Net Cash Flow | -37 | 45 | 14 | -37 | 26 | -127 | 115 | -69 | -286 | 417 | 3 |